Skip to content

A prospective, multicenter, clinical observational study on trifocal / astigmatism-correcting trifocal intraocular lenses for patients with cataract / presbyopia

A prospective, multicenter, clinical observational study on trifocal / astigmatism-correcting trifocal intraocular lenses for patients with cataract / presbyopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090510
Enrollment
Unknown
Registered
2024-10-08
Start date
2024-10-28
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract / Presbyopia

Interventions

Treatment group :Trifocal / Astigmatism-correcting Trifocal Intraocular Lens

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years old (including 18 and 85 years old), both men and women are eligible. 2. Meeting the diagnostic criteria for bilateral cataracts/presbyopia. 3. Patients who are planned to undergo implantation of trifocal/astigmatism-correcting trifocal intraocular lenses. 4. Able and willing to comply with all treatment and follow-up plans. 5. Voluntarily agree to participate in this study and provide written informed consent, unless informed consent can be waived after approval by the ethics committee.

Exclusion criteria

Exclusion criteria: 1. Irregular corneal astigmatism. 2. Systemic diseases that may affect postoperative results, such as patients with unstable blood sugar control in diabetes. 3. Amblyopia, strabismus, glaucoma, corneal diseases, severe fundus diseases and other ocular diseases that may affect postoperative results. 4. History of ocular trauma or other ocular surgery history that may confound the observation results. 5. Those who cannot follow up as prescribed. 6. Pregnant or lactating women. 7. Other situations where the investigator judges that the patient is not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
defocus curve;

Secondary

MeasureTime frame
corrected visual acuity;uncorrected visual acuity;subjective refraction.;IOL axial rotation;residual astigmatism;visual quality analysis;Patient satisfaction and visual function evaluation.;

Countries

China

Contacts

Public ContactGuo Tao

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

guotao9@hotmail.com+86 137 6492 3689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026